Intoplicine

DB12868InvestigationalSmall molecule

Intoplicine has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Chemical structure of Intoplicine
Formula / weight
C21H24N4O · 348.45 g/mol (avg)
Code names
RP 60475

Resolves to

Compound
UNIIFB2CIN6HMICAS125974-72-3ChEMBLCHEMBL1908351ChEBI135474PubChem65954
Structure
InChIKeyQROONAIPJKQFMC-UHFFFAOYSA-NSMILESCN(C)CCCNC1=NC=C(C)C2=C1C1=C(N2)C=CC2=CC(O)=CC=C12
Targets
P11387TOP1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Intoplicine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In